Letter to the EditorFull Access
Published Online:1 Jul 2004https://doi.org/10.1176/appi.ajp.161.7.1308
- Cited by
- 7 February 2022 | International Clinical Psychopharmacology, Vol. 37, No. 3
- 25 June 2020 | Clinical Neuropharmacology, Vol. 43, No. 4
- European Neuropsychopharmacology, Vol. 25, No. 10
- Journal of Clinical Psychopharmacology, Vol. 35, No. 4
- 8 November 2016 | Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, Vol. 21, No. 4
- Journal of Clinical Psychopharmacology, Vol. 31, No. 4
- Journal of Psychiatric Practice, Vol. 14, No. 6
- 1 September 2008 | Journal of Psychopharmacology, Vol. 22, No. 7
- Pharmacogenetics and Genomics, Vol. 18, No. 2
- 8 November 2006 | Journal of Psychopharmacology, Vol. 21, No. 6
- 1 January 2006 | Australian & New Zealand Journal of Psychiatry, Vol. 40, No. s1
- 1 May 2006 | American Journal of Psychiatry, Vol. 163, No. 5
- 22 November 2004 | Pharmacoepidemiology and Drug Safety, Vol. 13, No. 12